Recently, the DeBerardinis's group investigated metabolic disorders due to defects in the gene encoding lipoyltransferase-1 (LIPT1), which catalyzes the transfer of lipoic acid to the E2 subunits of 2-keto dehydrogenases, PDH and α-KGDH [230]. Here, LIPT1 is linked to metabolic disease.